IT-141

N/A

Report date: 2022/10/14 20:00:43
NME

Base Information

Drug NameIT-141
Drug Alias NameSN-38IT-141SN-38-nanoparticles-Intezyne-Technologies
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitorsDNA topoisomerase I inhibitors
TargetsTopoisomerase IIDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursLung NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntezyne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntezyne Technologies IncNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsSolid tumoursLung NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A